A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
Panel A shows spike protein sequences for the omicron BA.2, BA.2.75.2, XBB.1, BA.5, BF.7, and BQ.1.1 subvariants; mutations as compared with the WA1/2020 spike protein are shown. Mutations as compared ...
In a recent study published in the Proceedings of the National Academy of Sciences, researchers explored the shortcomings in mucosal immunoglobulin A (IgA) responses induced by existing vaccines ...
“Our results show how different factors boost the formation of antibodies that broadly combat different viral strains. This will pave the way for us to systematically push ahead with the development ...
When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...
(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...
Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...
The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies. Reporting Jan. 4 in the journal Cell, a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results